Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7482163 - Chemical reactivity determination for nanoparticles
Due to their high surface-to-volume ratio metal nanoparticles such as platinum serve as excellent catalysts for the manufacture of fuels, polymers and drugs. This patent from Nanostellar teaches a method for characterizing the reactivity to achieve better process control. Claim 1 reads:
1. A method of estimating chemical reactivity of a particle, comprising the steps of:
determining size and shape of the particle;
approximating atomic energy densities at various locations of atoms in the particle;
calculating local chemical softness values at said various locations of atoms based on the atomic energy densities;
calculating an average surface chemical softness of the particle based on the local chemical softness values; and
estimating the chemical reactivity of the particle based on the average surface chemical softness value of the particle.
Full post as published by TinytechIP on January 28, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Chemical Companies
alleging danger to people living near the plants.
Hazardous Chemical Spill
500 Evacuated from Denver Area Hospital
Chemical Plant Explosion
CHEMCENTRAL Midwest Corporation agrees to $375,000 settlement for safety violations.

When a figure is bad in a patent application.
CIGS: the next big thing in solar
Chemical Structure Searching in Free Patent Databases
Eisai Co. v. Dr. Reddy's Laboratories, Inc. (Fed. Cir. 2008)
Federal Circuit Rejects Patent Attorney Expert Testimony; Finds Patent Obvious
USPTO News: Agenda for Biotechnology Chemical Pharmaceutical Art Group Meeting








